Concepedia

Publication | Open Access

Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer

DOIFull Paper Access

73

Citations

66

References

2019

Year

Suriyan Ponnusamy, Yali He, Dong‐Jin Hwang, Thirumagal Thiyagarajan, René Houtman, Vera Bocharova, Bobby G. Sumpter, Elias J. Fernandez, Daniel L. Johnson, Ziyun Du,
Clinical Cancer Research

Abstract

Collectively, UT-34 exhibits the properties necessary for a next-generation prostate cancer drug.

References

YearCitations

Page 1